/PRNewswire/ - Diamond Therapeutics Inc. ("Diamond"), a drug development company focused on low-dose psychedelic therapies for use in the treatment of mental.
Toronto, Ontario (PRWEB) October 26, 2021 Toronto October 26, 2021Dalton Pharma Services, a leading North American Pharmaceutical cGMP CDMO is pleased to